56.27k followers • 31 symbols Watchlist by Yahoo Finance
Follow this list to discover and track penny stocks with the highest daily volume.
LUMN1.970.09%
Lumen Technologies, Inc.
GERN3.250.12%
Geron Corporation
GOEV0.590.02%
Canoo Inc.
FFIE0.220.01%
Faraday Future Intelligent Electric Inc.
QBTS1.670.42%
D-Wave Quantum Inc.
VSTM1.010.56%
Verastem, Inc.
OCGN0.460.01%
Ocugen, Inc.
DPLS0.010.00%
DarkPulse, Inc.
EFTR0.660.13%
eFFECTOR Therapeutics, Inc.
SFR0.320.12%
Appreciate Holdings, Inc.
SONN0.430.03%
Sonnet BioTherapeutics Holdings, Inc.
HPNN0.000.00%
Hop-On Inc.
ONFO1.400.23%
Onfolio Holdings, Inc.
GSAC0.000.00%
GelStat Corp.
TTCM0.000.00%
Tautachrome, Inc.
EEGI0.000.00%
Eline Entertainment Group, Inc.
FOMC0.000.00%
Fomo Worldwide, Inc.
RNVA0.000.00%
Rennova Health, Inc.
VXIT0.000.00%
VirExit Technologies, Inc.
GRST0.000.00%
Ethema Health Corporation
INTK0.000.00%
Industrial Nanotech, Inc.
BANT0.000.00%
Bantec, Inc.
RMRK0.000.00%
Rimrock Gold Corp.
TGHI0.000.00%
Touchpoint Group Holdings, Inc.
BEGI0.000.00%
BlackStar Enterprise Group, Inc.
ECOX0.000.00%
Eco Innovation Group, Inc.
GEGI0.000.00%
Genesis Electronics Group, Inc.
XCPL0.000.00%
XCPCNL Business Services Corporation
CBDD0.000.00%
CBD of Denver Inc.
CNNA0.010.00%
Cann American Corp.
Additional Capital will allow the Company to execute on its purchase ordersSalt Lake City, UT, May 26, 2023 (GLOBE NEWSWIRE) -- Salt Lake City, UT – May 26, 2023 – Genesis Electronics Group, Inc. (GEGI), the maker of the autonomous road-to-rail patent-pending shipping technology, Glīd, announced that it has executed loan agreements for a credit facility with 40 Brightwater, LLC, to borrow up to $750,000. The Loan is projected to close and fund, on or before, June 15, 2023. After their initial in
SOLANA BEACH, Calif. and REDWOOD CITY, Calif., May 26, 2023 (GLOBE NEWSWIRE) -- eFFECTOR Therapeutics, Inc. (NASDAQ: EFTR), a leader in the development of selective translation regulator inhibitors (STRIs) for the treatment of cancer, today announced that it has entered into a definitive agreement with a single healthcare-focused institutional investor for the purchase and sale of an aggregate of 11,450,382 shares of its common stock (or common stock equivalents in lieu thereof), at a purchase p
Lumen (LUMN) partners with WinMagic to provide customers with a comprehensive range of cybersecurity solutions.
WILMINGTON, Del., May 26, 2023 (GLOBE NEWSWIRE) -- Onfolio Holdings Inc. (Nasdaq: ONFO, ONFOW) (the “Company” or “Onfolio”), a holding company that acquires and manages a diversified portfolio of online businesses announces the launch of a powerful generative AI search function for MightyDeals.com, one of its subsidiaries. The team at Onfolio has been working hard to develop AI tools that can add value to each of our businesses. Onfolio’s AI is based on chatGPT-style Large Language Models, (LLMs
LOS ANGELES, May 26, 2023--Faraday Future Intelligent Electric Inc. (NASDAQ: FFIE) ("Faraday Future", "FF" or "Company"), a California-based global shared intelligent electric mobility ecosystem company, today announced that the FF 91 EV successfully passed the Federal Motor Vehicle Safety Standard (FMVSS) crash test requirements. FF has performed the highest severity crash tests and has passed all of these tests successfully, including front, side and rear crash tests.
BOSTON, May 25, 2023--Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with cancer, today announced updated data from Part A of the ongoing registration-directed RAMP 201 (ENGOTov60/GOG3052) trial evaluating the safety and efficacy of avutometinib (VS-6766) alone and in combination with defactinib among patients with recurrent low-grade serous ovarian cancer (LGSOC).
FOSTER CITY, Calif., May 25, 2023--Geron Corporation (Nasdaq: GERN), a late-stage clinical biopharmaceutical company, today announced acceptance of its IMerge Phase 3 abstract as an oral presentation at the upcoming 2023 American Society of Clinical Oncology (ASCO) Annual Meeting. This abstract describes statistically significant positive efficacy and safety data from the pivotal IMerge Phase 3 clinical trial evaluating the Company’s first-in-class telomerase inhibitor, imetelstat, in lower risk
Partial responses observed in 5 of 19 (26%) evaluable patients treated with zotatifin 0.07 mg/kg combined with fulvestrant and abemaciclib (ZFA triplet) in heavily pretreated populationPartial response observed in 1 of 3 (33%) patients treated with zotatifin 0.1 mg/kg combined with fulvestrant (ZF doublet)Both combinations were generally well tolerated with large majority of adverse events Grade 1 or 2Company will host a virtual investor call on June 4, 2023, to discuss the data and clinical pro
Wall Street has high hopes for certain stocks over the coming 12 months. Two of them are biotech companies that took center stage during earlier days of the pandemic. Both companies raced to bring a coronavirus vaccine to market.
New partnership leverages expertise in network, security and cloud solutionsMISSISSAUGA, Ontario, May 25, 2023 (GLOBE NEWSWIRE) -- WinMagic Inc. (the "Company" or "WinMagic") is proud to announce that it is now a member of the Lumen Technologies (NYSE: LUMN) Channel Partner program. WinMagic offers powerfully simple and seamless authentication and encryption solutions that use the endpoint to deliver unbeatable security. This partnership will enable the Company to leverage Lumen’s extensive netw
Canoo (NASDAQ: GOEV) stock is seeing significant sell-offs in Wednesday's trading. The electric vehicle (EV) company's share price was down roughly 6.3% in the daily session as of 11:30 a.m. ET, according to data from S&P Global Market Intelligence. While there wasn't any fresh news directly related to Canoo's business, recent earnings results from another player in the EV space suggest that demand may be weakening in the market.
Pop quiz: Which central bank has probably just finished its most aggressive series of interest-rate increases in decades? In the last 18 months, it has raised interest rates from close to zero to more than 5%.
MALVERN, Pa., May 24, 2023 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Nasdaq: OCGN), a biotechnology company focused on discovering, developing, and commercializing novel gene and cell therapies, biologics, and vaccines, today announced the pricing of its underwritten public offering of 30,000,000 shares of its common stock for gross proceeds of $16.5 million, before deducting the underwriting discounts and commissions and other estimated offering expenses payable by Ocugen. The offering is expected to c
Li Auto, Stellantis, General Motors, Lightning eMotors and Canoo are included in this Analyst Blog.
LOS ANGELES, May 24, 2023--Faraday Future Intelligent Electric Inc. (Nasdaq: FFIE) ("Faraday Future", "FF" or "Company"), a California-based global shared intelligent electric mobility ecosystem company, today announced that it is seeking public opinion through an online survey on changing FF’s stock ticker from "FFIE" to "FFAI."
While talks between both political parties continue over the lifting of the U.S. government's $31.4 trillion debt ceiling, any progress seems to be hard won and there are few signs of a deal being reached anytime soon. There’s now just over a week before the early-June deadline that U.S. Treasury Secretary Janet Yellen said is when it’s “highly likely” that her department will run out of sufficient cash to function as normal.
Investing.com -- The Reserve Bank of New Zealand hiked interest rates as expected on Wednesday and said that rates will remain higher for longer given stubborn inflation, although local economic growth is likely to suffer as a result of monetary tightening.
MALVERN, Pa., May 23, 2023 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Nasdaq: OCGN), a biotechnology company focused on discovering, developing, and commercializing novel gene and cell therapies, biologics, and vaccines, today announced that it has commenced an underwritten public offering of its common stock. In addition, Ocugen expects to grant to the underwriter a 30-day option to purchase up to an additional 15% of shares of the common stock sold in the public offering. All of the securities in the o
MALVERN, Pa., May 23, 2023 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a biotechnology company focused on discovering, developing, and commercializing novel gene and cell therapies, biologics, and vaccines, today announced that the Company will present at the 2023 BIO International Convention taking place in Boston, Mass. from June 5-8, 2023. During the conference, members of the Ocugen team will host meetings with pharmaceutical executives to explore partnering and
Artificial Intelligence (AI) has been a hot topic in the world of trading for decades. Will AI ever be able to outperform humans in making potentially profitable decisions?
LOS ANGELES, May 22, 2023--Faraday Future Intelligent Electric Inc. (Nasdaq: FFIE) ("Faraday Future", "FF" or "Company"), a California-based global shared intelligent electric mobility ecosystem company, today announced the countdown to its FF 91 Final Launch & Faraday Future 2.0 event, set to occur on May 30th.
Fool.com contributor and finance professor Parkev Tatevosian picks his favorite between Canoo (NASDAQ: GOEV) and QuantumScape (NYSE: QS) stocks. *Stock prices used were the afternoon prices of May 19, 2023.
LOS ANGELES, May 22, 2023--Faraday Future Intelligent Electric Inc. (Nasdaq: FFIE) ("Faraday Future", "FF" or "Company"), a California-based global shared intelligent electric mobility ecosystem company, today announced its newly established "Mission Farad," designed to encompass the Company’s many benefits to its user-based co-creation philosophy.
Canoo (NASDAQ: GOEV) is facing a serious liquidity crunch. The electric vehicle start-up recently raised capital with the sale of debt that could trigger a massive monthly cash expense for the company, based on something completely out of management's control.
Long term investing works well, but it doesn't always work for each individual stock. We really hate to see fellow...